Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
2-Hydroxypropyl-β-cyclodextrin: Solubility Protocol and Limi
2026-05-25
2-Hydroxypropyl-β-cyclodextrin enhances the aqueous solubility of poorly water-soluble, hydrophobic compounds, particularly those containing aromatic or phenyl groups, by forming inclusion complexes. It is suitable for use as a drug formulation excipient in pharmaceutical and biochemical research workflows focused on solubility improvement. Broader or therapeutic uses are not supported by current product documentation.
-
GANT61 and GLI2: Unraveling Immune Evasion in Cancer Models
2026-05-25
Explore how GANT61, a selective GLI inhibitor, uniquely dissects the role of GLI2 in tumor immune evasion and guides advanced cancer research workflows. This article reveals mechanistic insights and practical assay strategies not covered by standard protocol guides.
-
D-Luciferin: Enhancing Bioluminescent Imaging in Tumor Immun
2026-05-24
D-Luciferin empowers precise, non-invasive monitoring of tumor progression and immune cell dynamics in living models, elevating both experimental rigor and translational impact. Its high-affinity firefly luciferase substrate chemistry makes it indispensable for ATP quantification and real-time gene expression assays across oncology and immunotherapy research.
-
CCG-1423: Precision RhoA Inhibitor Workflows in Cancer and V
2026-05-23
CCG-1423 empowers researchers to dissect RhoA/ROCK signaling with unprecedented specificity, enabling high-resolution analysis of cancer cell invasion and viral pathogenesis. Its unique inhibition of MRTF-A/importin α/β1 unlocks new avenues for apoptosis assays and tight junction studies, making it an essential tool in translational research.
-
Genistein in Cytoskeleton-Dependent Autophagy Assays
2026-05-22
Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) is a selective tyrosine kinase inhibitor that empowers high-precision studies of autophagy and cancer chemoprevention. This guide details protocol enhancements, troubleshooting, and advanced workflow design for leveraging Genistein in cytoskeleton-dependent cell-based assays, informed by the latest mechanistic and experimental insights.
-
Dacarbazine: Applied Protocols for Oncology Research Success
2026-05-22
Dacarbazine stands out as a gold-standard antineoplastic chemotherapy drug, enabling high-fidelity modeling of cancer DNA damage pathways in malignant melanoma, Hodgkin lymphoma, and sarcoma. This article delivers actionable workflows, expert troubleshooting, and reference-backed optimization tips to maximize experimental reproducibility and translational impact.
-
ICOS Signaling Drives Th2 Differentiation in Allergic Rhinit
2026-05-21
This study identifies inducible co-stimulator (ICOS) signaling as a central regulator of T cell subset differentiation, particularly Th2 cells, in allergic rhinitis (AR). The findings reveal ICOS-expressing Th2 cells as potential therapeutic targets and clarify how PI3K-Akt-mTOR pathway modulation impacts immune responses in AR.
-
Caspofungin: Advanced Insights for β-(1,3)-D-Glucan Inhibiti
2026-05-21
Explore how Caspofungin, a lipopeptide antifungal drug, empowers innovative research into fungal cell wall biosynthesis inhibition. This article delivers a technical deep dive into assay design, resistance management, and practical workflow optimization, uniquely extending beyond existing resources.
-
LY2603618 Chk1 Inhibitor: Applied Workflows & Troubleshootin
2026-05-20
LY2603618 stands out as a highly selective Chk1 inhibitor, enabling precise modulation of the DNA damage response and enhancing cancer chemotherapy sensitization. This guide details validated protocols, advanced use-cases, and expert troubleshooting to maximize reproducibility and performance in oncology research.
-
Standardizing 3D Tumor Spheroid Assays for Glioblastoma Stem
2026-05-20
This study introduces a streamlined 3D-tumor spheroid assay to functionally assess the stemness of glioblastoma cell lines. The protocol enhances reproducibility, reduces time and resources, and is well-suited for high-throughput screening and mechanistic studies in glioma research.
-
Machine Learning Uncovers Novel Senolytics for Senescent Cel
2026-05-19
The reference study demonstrates the use of cost-effective machine learning algorithms to identify new senolytic compounds capable of selectively eliminating senescent cells. This approach substantially reduces screening costs and opens new avenues for targeted therapies in cancer and age-related diseases.
-
SU 5402 (SKU A3843): Data-Backed Solutions for Cell-Based As
2026-05-19
This article provides an evidence-based, scenario-driven exploration of SU 5402 (SKU A3843), focusing on its reliability and performance in cell viability, proliferation, and apoptosis assays. Drawing on published literature and real laboratory challenges, it guides biomedical researchers and technicians on optimizing protocols and vendor selection for reproducible tyrosine kinase inhibition studies.
-
Carboxylesterase Interference in Mitochondrial H2O2 Assays:
2026-05-18
Miwa et al. (2016) demonstrate that carboxylesterases can directly convert Amplex Red to resorufin independently of hydrogen peroxide, distorting mitochondrial H2O2 release measurements. This work urges re-evaluation of widely used ROS detection protocols and provides corrective strategies to enhance assay specificity.
-
Moxidectin: Macrocyclic Lactone Anthelmintic in Antifungal M
2026-05-18
Moxidectin, a macrocyclic lactone anthelmintic, is emerging as a pivotal agent not only for parasitic worm control in veterinary medicine but also as a powerful enhancer of polyene antifungal efficacy. This article decodes practical workflows, protocol refinements, and troubleshooting tips for leveraging high-purity moxidectin from APExBIO in translational research on Candida albicans and beyond.
-
SAG: Smoothened Receptor Agonist for Advanced Assay Design
2026-05-17
Smoothened Agonist (SAG) unlocks precise Hedgehog pathway activation for mitochondrial, neuroprotection, and developmental models. This guide delivers actionable workflows, protocol parameters, and troubleshooting strategies, translating recent research into robust, reproducible lab results.